Immuneering (IMRX) Shares Outstanding (2020 - 2022)
Historic Shares Outstanding for Immuneering (IMRX) over the last 3 years, with Q4 2022 value amounting to $26.4 million.
- Immuneering's Shares Outstanding rose 37.44% to $26.4 million in Q4 2022 from the same period last year, while for Dec 2022 it was $26.4 million, marking a year-over-year increase of 37.44%. This contributed to the annual value of $26.4 million for FY2022, which is 37.44% up from last year.
- Per Immuneering's latest filing, its Shares Outstanding stood at $26.4 million for Q4 2022, which was up 37.44% from $26.4 million recorded in Q3 2022.
- Over the past 5 years, Immuneering's Shares Outstanding peaked at $26.4 million during Q4 2022, and registered a low of $5.0 million during Q2 2020.
- For the 3-year period, Immuneering's Shares Outstanding averaged around $16.6 million, with its median value being $25.9 million (2021).
- Data for Immuneering's Shares Outstanding shows a peak YoY increase of 43298.2% (in 2022) and a maximum YoY decrease of 37.44% (in 2022) over the last 5 years.
- Over the past 3 years, Immuneering's Shares Outstanding (Quarter) stood at $5.0 million in 2020, then skyrocketed by 431.71% to $26.3 million in 2021, then rose by 0.37% to $26.4 million in 2022.
- Its Shares Outstanding stands at $26.4 million for Q4 2022, versus $26.4 million for Q3 2022 and $26.4 million for Q2 2022.